Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : For entities : Sanofi save search
Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published: 2024-04-19 (Crawled : 15:00) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
first treatment for
Quebec's INESSS recommends BEYFORTUS for the prevention of RSV for all infants 8 months of age and younger(1)
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.81%
H: 0.0%
C: 0.0%
beyfortus for rsv
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
Published: 2024-04-17 (Crawled : 05:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
sclerosis for potential
World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders"
Published: 2024-04-17 (Crawled : 04:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
day bleeding world for
AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12 (Crawled : 14:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: -2.94%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -1.06%
H: 0.21%
C: -1.05%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
drug label astrazeneca expansion for kids
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: 0.96%
H: 1.17%
C: 0.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.09%
H: 0.16%
C: -0.7%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
for
FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: -0.22%
H: 0.8%
C: 0.06%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.37%
H: 1.42%
C: 1.37%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
fda for
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.